Mark G. Vartanian

1.5k total citations
30 papers, 1.2k citations indexed

About

Mark G. Vartanian is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Mark G. Vartanian has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Cellular and Molecular Neuroscience and 8 papers in Organic Chemistry. Recurrent topics in Mark G. Vartanian's work include Neuroscience and Neuropharmacology Research (14 papers), Ion channel regulation and function (7 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Mark G. Vartanian is often cited by papers focused on Neuroscience and Neuropharmacology Research (14 papers), Ion channel regulation and function (7 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Mark G. Vartanian collaborates with scholars based in United States, United Kingdom and China. Mark G. Vartanian's co-authors include Charles P. Taylor, Po‐wai Yuen, Ryszard Andruszkiewicz, Richard B. Silverman, Gerald P. Schielke, Jack J. Kinsora, Devin Welty, Nirmala Suman‐Chauhan, Peter A. Boxer and Roy D. Schwarz and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Medicinal Chemistry and European Journal of Pharmacology.

In The Last Decade

Mark G. Vartanian

30 papers receiving 1.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mark G. Vartanian 521 516 336 253 252 30 1.2k
Nirmala Suman‐Chauhan 909 1.7× 816 1.6× 208 0.6× 344 1.4× 420 1.7× 39 1.7k
Lars J. S. Knutsen 665 1.3× 603 1.2× 259 0.8× 214 0.8× 78 0.3× 36 1.2k
Cen Xu 775 1.5× 615 1.2× 263 0.8× 797 3.2× 185 0.7× 52 1.9k
Tadahiko Karasawa 385 0.7× 319 0.6× 97 0.3× 300 1.2× 116 0.5× 63 983
Joseph F. Gardocki 529 1.0× 454 0.9× 417 1.2× 619 2.4× 190 0.8× 30 1.8k
James J. Schupsky 321 0.6× 302 0.6× 96 0.3× 280 1.1× 257 1.0× 14 939
Matthew E. Barton 529 1.0× 420 0.8× 88 0.3× 341 1.3× 171 0.7× 28 1.0k
F.D. Tattersall 802 1.5× 774 1.5× 204 0.6× 117 0.5× 415 1.6× 30 2.0k
Gabriele Micheletti 1.5k 2.8× 959 1.9× 451 1.3× 801 3.2× 143 0.6× 111 2.6k
Aron D. Mosnaim 378 0.7× 351 0.7× 101 0.3× 294 1.2× 205 0.8× 85 1.3k

Countries citing papers authored by Mark G. Vartanian

Since Specialization
Citations

This map shows the geographic impact of Mark G. Vartanian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark G. Vartanian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark G. Vartanian more than expected).

Fields of papers citing papers by Mark G. Vartanian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark G. Vartanian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark G. Vartanian. The network helps show where Mark G. Vartanian may publish in the future.

Co-authorship network of co-authors of Mark G. Vartanian

This figure shows the co-authorship network connecting the top 25 collaborators of Mark G. Vartanian. A scholar is included among the top collaborators of Mark G. Vartanian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark G. Vartanian. Mark G. Vartanian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ward, Brent B., Baohua Huang, Ankur Desai, et al.. (2012). Sustained Analgesia Achieved Through Esterase-Activated Morphine Prodrugs Complexed with PAMAM Dendrimer. Pharmaceutical Research. 30(1). 247–256. 15 indexed citations
2.
Wustrow, David J., Thomas R. Belliotti, Thomas Capiris, et al.. (2008). Oxadiazolone bioisosteres of pregabalin and gabapentin. Bioorganic & Medicinal Chemistry Letters. 19(1). 247–250. 11 indexed citations
3.
Thompson, Lisa R., Clare O. Kneen, Simon A. Osborne, et al.. (2005). Carboxylate bioisosteres of gabapentin. Bioorganic & Medicinal Chemistry Letters. 16(9). 2333–2336. 17 indexed citations
4.
Vartanian, Mark G., Louis L. Radulovic, Jack J. Kinsora, et al.. (2005). Activity profile of pregabalin in rodent models of epilepsy and ataxia. Epilepsy Research. 68(3). 189–205. 82 indexed citations
5.
Yuen, Po‐wai, et al.. (2005). Heteroaromatic side-chain analogs of pregabalin. Bioorganic & Medicinal Chemistry Letters. 16(9). 2329–2332. 14 indexed citations
6.
Rafferty, Michael, David Dooley, Susan M. Lotarski, et al.. (1999). Structure-activity relationship of N-methyl-N-aralkyl-peptidylamines as novel N-type calcium channel blockers. Bioorganic & Medicinal Chemistry Letters. 9(15). 2151–2156. 19 indexed citations
7.
Hu, Lain‐Yen, Todd R. Ryder, Michael Rafferty, et al.. (1999). N,N-Dialkyl-dipeptidylamines as novel N-type calcium channel blockers. Bioorganic & Medicinal Chemistry Letters. 9(6). 907–912. 14 indexed citations
8.
Shivers, Brenda D., Peter A. Boxer, Karen M. Keane, et al.. (1998). Contribution of the ICE Family to Neurodegeneration. Annals of the New York Academy of Sciences. 840(1). 59–64. 3 indexed citations
9.
Vartanian, Mark G., Nancy C. Kupina, Gerald P. Schielke, et al.. (1996). Phenytoin pretreatment prevents hypoxic-ischemic brain damage in neonatal rats. Developmental Brain Research. 95(2). 169–175. 25 indexed citations
10.
Bigge, Christopher F., et al.. (1995). Potent, Orally Active, Competitive N-Methyl-D-aspartate (NMDA) Receptor Antagonists Are Substrates for a Neutral Amino Acid Uptake System in Chinese Hamster Ovary Cells. Journal of Medicinal Chemistry. 38(11). 1955–1965. 20 indexed citations
11.
Hays, Sheryl J., Michael J. Rice, Daniel F. Ortwine, et al.. (1994). Substituted 2-Benzothiazolamines as Sodium Flux Inhibitors: Quantitative Structure-Activity Relationships and Anticonvulsant Activity. Journal of Pharmaceutical Sciences. 83(10). 1425–1432. 96 indexed citations
12.
Yuen, Po‐wai, et al.. (1994). Enantioselective synthesis of PD144723: a potent stereospecific anticonvulsant.. Bioorganic & Medicinal Chemistry Letters. 4(6). 823–826. 68 indexed citations
13.
Welty, Devin, Gerald P. Schielke, Mark G. Vartanian, & Charles P. Taylor. (1993). Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in plasma and brain microdialysate. Epilepsy Research. 16(3). 175–181. 107 indexed citations
14.
15.
Taylor, Charles P., Mark G. Vartanian, Ryszard Andruszkiewicz, & Richard B. Silverman. (1992). 3-Alkyl GABA and 3-alkylglutamic acid analogues: two new classes of anticonvulsant agents. Epilepsy Research. 11(2). 103–110. 85 indexed citations
16.
Taylor, Charles P. & Mark G. Vartanian. (1992). Probenecid pretreatment enhances anticonvulsant action of NBQX in mice. European Journal of Pharmacology. 213(1). 151–153. 27 indexed citations
17.
Pavia, Michael R., David A. Nugiel, V. Gregor, et al.. (1992). Structure-activity studies on benzhydrol-containing nipecotic acid and guvacine derivatives as potent, orally-active inhibitors of GABA uptake. Journal of Medicinal Chemistry. 35(22). 4238–4248. 32 indexed citations
18.
Silverman, Richard B., Ryszard Andruszkiewicz, Shrenik M. Nanavati, Charles P. Taylor, & Mark G. Vartanian. (1991). 3-Alkyl-4-aminobutyric acids: the first class of anticonvulsant agents that activates L-glutamic acid decarboxylase. Journal of Medicinal Chemistry. 34(7). 2295–2298. 78 indexed citations
19.
Vartanian, Mark G. & Charles P. Taylor. (1991). Different stereoselectivity of the enantiomers of HA-966 (3-amino-1-hydroxy-2-pyrrolidinone) for neuroprotective and anticonvulsant actions in vivo. Neuroscience Letters. 133(1). 109–112. 28 indexed citations
20.
Taylor, Charles P., Mark G. Vartanian, Roy D. Schwarz, et al.. (1990). Pharmacology of Cl‐966: A potent GABA uptake inhibitor, in vitro and in experimental animals. Drug Development Research. 21(3). 195–215. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nirmala Suman‐Chauhan Breakdown of academic impact, for papers by Lars J. S. Knutsen Breakdown of academic impact, for papers by Cen Xu Breakdown of academic impact, for papers by Tadahiko Karasawa Breakdown of academic impact, for papers by Joseph F. Gardocki Breakdown of academic impact, for papers by James J. Schupsky Breakdown of academic impact, for papers by Matthew E. Barton Breakdown of academic impact, for papers by F.D. Tattersall Breakdown of academic impact, for papers by Gabriele Micheletti Breakdown of academic impact, for papers by Aron D. Mosnaim
Rankless by CCL
2026